Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ytterby Life Science AB
AB
Active
Org 5590692801
Öregrundsgatan 18, 115 59
Stockholm
Business and other management consultancy activities
· NACE 7020
Est. 2016
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Ytterby Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2021
1M
2022
1M
2023
1M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 071
1 258
1 376
1 088
1 587
Staff expenses
—
—
—
−812
−821
EBITDA
246
243
231
44
435
Depreciation & amort.
−0
−0
−0
—
—
EBIT
246
243
231
44
435
Net financials
45
100
112
22
19
Profit before tax
216
278
279
42
372
Tax
−47
−41
−40
−15
−83
Net profit
169
237
239
27
289
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
392
543
611
421
842
Equity
220
297
296
83
342
Long-term debt
0
0
0
—
—
Short-term debt
44
54
58
57
137
Total debt
44
54
58
57
137
Financial ratios
5-year trend
EBITDA margin
27.4%
This company
15.8%
Market median
+73% vs market
2021
2025
Equity ratio
40.6%
This company
38.2%
Market median
+6% vs market
2021
2025
Return on equity
84.5%
This company
18.4%
Market median
+359% vs market
2021
2025
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
2021
2025
Asset turnover
1.89×
This company
1.12×
Market median
+69% vs market
2021
2025
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ytterby Life Science AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
